The use of this virus pro-drug combination has also been shown to result in an increase of immune cell activity within murine brain tumors, with a decrease in immunosuppressive cells and an increase in interferon gamma positive CD8 T cells within the tumor microenvironment (194). Here, CD8A is linked to neoplasm.